SCHEMBL21499320

SCHEMBL21499320

COc1cc2c(cc1NC(=O)c1ccc(C(=O)O)cc1)CCCCC2

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.77
MAPT P10636 5/20 0.75
LMNA P02545 4/20 0.75
ALDH1A1 P00352 3/20 0.75
SMN1; SMN2 Q16637 3/20 0.75
HTT P42858 2/20 0.75
HPGD P15428 1/20 0.75
KDM4E B2RXH2 2/20 0.70
CYP1A2 P05177 1/20 0.70
CYP3A4 P08684 1/20 0.70
CYP2C19 P33261 1/20 0.70
RAB9A P51151 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALOX15 P16050 1/20 0.59
NPSR1 Q6W5P4 2/20 0.57
TP53 P04637 2/20 0.50
GAA P10253 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21468511 0.91 DHODH (0.75) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468502 0.88 DHODH (0.76) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468525 0.88 DHODH (0.76) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468457 0.87 DHODH (1.00) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468533 0.87 DHODH (0.74) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468515 0.86 DHODH (0.80) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468461 0.86 DHODH (0.72) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468534 0.86 DHODH (0.72) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468478 0.86 DHODH (0.84) DHODHMAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL21468446 0.85 DHODH (0.71) DHODHMAPTLMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 DHODH 593/4885MAPT 760/4885LMNA 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.